29 August 2024
The National Medical Research Radiological Center of the Ministry of Health of the Russian Federation has become the first in the country to receive certification for in-house pharmaceutical production. This milestone allows the center to manufacture drugs tailored specifically for their patients’ needs.
The document allows the production of biomedical cell products and high-tech drugs. “Certified production helps in solving acute problems of import substitution of drugs, opens up prospects for the development of personalized medicine in the country. In addition, a high level of technical support facilitates the solution of many clinical and scientific problems of Russian oncology,” the report says.
“This is a truly great achievement of the Center, and it opens up opportunities for the production of super-precision drugs and, of course, for conducting promising scientific research,” emphasized the Chief oncologist of the Ministry of Health of the Russian Federation Andrey Kaprin.
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
DSM Group predicts the Russian pharmaceutical market will grow by 10% annually
18 October 2024
An extra 6.1 billion rubles will be allocated for drug provision in 2025
18 October 2024
Pharmasyntez to build heparin production plant in Tatarstan
17 October 2024
17 October 2024